Clarins
This article was originally published in The Rose Sheet
Executive Summary
David Yurman beauty and fragrance products will launch under a partnership between the fine jewelry company and Clarins Groupe USA, French beauty firm announces Oct. 5. Items will be positioned as prestige offerings, with the first fragrance launching principally in the U.S. and Canada, company says. Yurman's "distinct identity and strong brand values" make it the "ideal platform for the launch of unique fragrances," Clarins notes. The jewelry firm adds the partnership is a good fit due to the companies' shared commitment to maintaining brand integrity. The deal is the latest in a string of luxury fragrance partnerships, including BeautyBank and bag designer Coach and Inter Parfums and fine jewelry marketer Van Cleef & Arpels (1"The Rose Sheet" Sept. 25, 2006, Marketing in Brief and 2"The Rose Sheet" Oct. 9, 2006, In Brief)...
You may also be interested in...
Marketing In Brief
BeautyBank: Coach fragrances and complementary products will debut under a partnership between the designer accessories brand and BeautyBank, the Estee Lauder division announces Sept. 22. Fragrances will embody the "many personalities of the Coach woman," with the first scent slated to launch in Spring 2007, positioned as a fresh and sophisticated offering, according to Coach. The agreement allows Coach to enter an "entirely new" product category under the belief that "fragrance will provide additional reasons for our customers to visit and purchase in Coach stores," firm notes...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.